The End Prescription Drug Ads Now Act aims to eliminate direct-to-consumer drug advertising across all media platforms, ...

Eli Lilly & Co. and health tech company Kalderos Inc. are seeking to revive lawsuits in the DC Circuit after a federal judge ...

Industry sources reveal drug companies have stopped negotiating listings on the PBS and in some cases are considering not ...

Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

(Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...

The price of weight loss drugs is falling, making them more accessible to consumers, and the price could get driven even lower.Highly sought-after drugs like Wegovy and Zepbound both retail at roughly ...